Clinical Trial Update: Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy [Phase 4]

View source ↗

Summary

This report notes the completion of a Phase 4 pharmacovigilance study (SKATE) evaluating the safety of Keppra (levetiracetam) as adjunctive therapy in epilepsy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 4 | Status: COMPLETED